These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8336400)

  • 41. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.
    Coburn JW; Brickman AS; Sherrard DJ; Singer FR; Wong EG; Baylink DJ; Norman AW
    Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Potentials for the early diagnosis of renal osteodystrophy in patients with chronic kidney failure during treatment by systematic hemodialysis].
    Shcherbakova EO; Fekson EG; Cherniakov VL; Shcherbakov VA
    Urol Nefrol (Mosk); 1985; (2):58-60. PubMed ID: 3992758
    [No Abstract]   [Full Text] [Related]  

  • 44. Parathyroid suppressibility in renal osteodystrophy.
    Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Ku G; Sweatman AJ; Wills MR
    Proc Eur Dial Transplant Assoc; 1975; 11():465-72. PubMed ID: 1197271
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
    Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC
    J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 47. PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure.
    Franke S; Lehmann G; Abendroth K; Hein G; Stein G
    Eur J Med Res; 1998 Feb; 3(1-2):81-8. PubMed ID: 9512973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy.
    Gonzalez MT; Gonzalez C; Griñó JM; Castelao AM; Mariñoso ML; Serrano S; Bonnin R; Carreras L; Alsina J
    Transplant Proc; 1990 Aug; 22(4):1407-11. PubMed ID: 2389341
    [No Abstract]   [Full Text] [Related]  

  • 50. Non-protein-bound hydroxyproline in plasma in renal bone disease.
    Bishop MC; Smith R
    Clin Chim Acta; 1971 Jul; 33(2):403-8. PubMed ID: 5119316
    [No Abstract]   [Full Text] [Related]  

  • 51. [Loss of bone substance in long-term dialysis--the value of serochemical parameters].
    Schober HC; Abendroth K; Osten B; Kunkel S
    Z Urol Nephrol; 1989 Oct; 82(10):515-9. PubMed ID: 2609801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Aluminum in renal osteodystrophy].
    Zhu P; Wang GY; Yu YF; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):176-8. PubMed ID: 8222983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.
    Jablonski G; Danielsen CC; Mosekilde L; Gordeladze JO
    Calcif Tissue Int; 1994 Oct; 55(4):281-7. PubMed ID: 7820779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF; Hu YX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques.
    Hodson EM; Howman-Giles RB; Evans RA; Bautovich G; Hills EE; Sherbon K; Bach BD; Horvath JS; Tiller DJ
    Clin Nephrol; 1981 Jul; 16(1):24-8. PubMed ID: 6268343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Advances of clinical diagnosis of osteodystrophy complicated by chronic renal failure].
    Nowak Z
    Pol Merkur Lekarski; 1998 Nov; 5(29):313-6. PubMed ID: 10101511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.